Should We Use Immunodominant DSA to Measure Response to Therapy in Antibody-mediated Rejection? Yabu JM. Transplantation 2020;104:2260-2261.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yabu JM. Should We Use Immunodominant DSA to Measure Response to Therapy in Antibody-mediated Rejection? Transplantation 2020;104:2260-2261.
PMID: 32000257